JUPITER, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will hold a conference call beginning at 8:30 a.m. ET to discuss the results and provide a general business update. Conference […]
Category Archives: Pr Newswire
Pr Newswire
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals
12
Feb
Feb
CC Pharma Agreement Bolsters Tilray’s UK Growth, Strengthening Distribution to Pharmacy and Hospital Channels NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) — Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution business, CC Pharma, has entered into a strategic agreement with Smartway Pharmaceuticals, […]
Pr Newswire
Arvinas Announces Appointment of Randy Teel, Ph.D., as President, Chief Executive Officer, and Director
12
Feb
Feb
– Appointment of an experienced Arvinas executive with a proven ability to drive strategy and innovation positions the company for continued momentum and long-term growth – NEW HAVEN, Conn., Feb. 12, 2026 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today […]
HONG KONG, Feb. 12, 2026 /PRNewswire/ — On February 11, the orthopaedic surgical robot with originally developed HX Orthopaedic-Specific Robotic Arm, which was 100% homemade by Yuanhua Robotics, Perception and AI Technologies Ltd. (hereinafter referred to as “Yuanhua Tech”), saw its first clinical success at West China Hospital of Sichuan University. This milestone achievement signifies that […]
APIA, Samoa, Feb. 12, 2026 /PRNewswire/ — Phemex, a user-first crypto exchange, unveils Phemex Astral Trading League (PATL), a standing constellation-themed competition framework that reframes how crypto derivatives contests operate. Rather than running periodic promotional futures trading races, the exchange has consolidated its recurring daily, weekly, and monthly competitions into a structured, season-based league designed […]
Agreement is expected to lead to commercial revenue for 2026 DALLAS, Feb. 12, 2026 /PRNewswire/ — Solidion Technology, Inc. (“Solidion” or the “Company”) (Nasdaq: STI), an advanced battery technology solutions provider, announced that it has entered into a non-binding Memorandum of Understanding (“MOU”) with an entity that manufactures and distributes energy storage systems to supply […]
SHANGHAI, Feb. 12, 2026 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced it plans to release its unaudited financial results for fourth quarter and fiscal year ended December 31, 2025, before U.S. markets open on Thursday, February […]
LISBON, Portugal, Feb. 12, 2026 /PRNewswire/ — Feedzai, the leading AI-native RiskOps platform provider for end-to-end financial crime prevention, and Neterium, a RegTech specialising in cutting-edge screening technology, are joining forces in a strategic partnership to deliver a unified, best-in-class offering that meets the market’s growing demand for a holistic view of risk by integrating […]
12
Feb
Feb
RADNOR, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on February 9, 2026, the Compensation Committee of […]
Pr Newswire
High Survival Rates With Ryoncil® in EIND Program Emphasize Importance of Earlier Use in Both Children and Adults With SR-aGvHD
12
Feb
Feb
NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided data presented at the February 2026 Tandem Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, […]